← Back to Search

Barrier Method

Ovaprene for Birth Control

N/A
Recruiting
Research Sponsored by Daré Bioscience, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Sexually active people assigned female at birth, at risk for pregnancy and desiring contraception
Have regular menstrual cycles (when not on hormonal contraception) with a usual length of 21 to 35 days, without heavy bleeding that lasts longer than 5 days
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial will study a new, non-hormonal contraceptive ring for safety, effectiveness, and acceptability.

Who is the study for?
This trial is for sexually active individuals assigned female at birth, aged 18-40, in good health and not wanting pregnancy for at least 13 months. They must be willing to use Ovaprene as their only birth control method during the study and have regular menstrual cycles. Partners should be male, over 18, and not known to be subfertile.Check my eligibility
What is being tested?
The study tests Ovaprene's effectiveness as a non-hormonal contraceptive. Participants will use this intravaginal ring exclusively for birth control. The trial is open-label and conducted across multiple centers to assess safety and acceptability.See study design
What are the potential side effects?
Specific side effects are not listed here but may include typical reactions associated with intravaginal devices such as discomfort, discharge or infection risk due to foreign body presence.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am sexually active, can become pregnant, and want birth control.
Select...
My menstrual cycles are regular, lasting 21 to 35 days without prolonged heavy bleeding.
Select...
I agree to use only Ovaprene for birth control during the study.
Select...
I am between 18 and 40 years old.
Select...
I am 18 or older and not known to have fertility issues.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Determination of pregnancy rate

Trial Design

1Treatment groups
Experimental Treatment
Group I: OvapreneExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ovaprene
2018
N/A
~40

Find a Location

Who is running the clinical trial?

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,965 Previous Clinical Trials
2,672,141 Total Patients Enrolled
Daré Bioscience, Inc.Lead Sponsor
9 Previous Clinical Trials
926 Total Patients Enrolled
Christine Mauck, MDStudy DirectorDaré Bioscience, Inc.
1 Previous Clinical Trials
21 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research program open to individuals below the age of 70?

"Applicants eligible for this trial must be between 18 and 40 years of age."

Answered by AI

Is there still the capacity to include new participants in this trial?

"At this time, the clinical trial posted on December 1st 2023 is not actively recruiting. The most recent update to the listing was made November 14th 2023. However, there are 56 other trials currently enrolling patients into their studies."

Answered by AI

What are the eligibility criteria for participating in this research study?

"In order to be considered for admittance into this medical trial, the participants must demonstrate contraceptive measures and should have a birthdate between 18-40 years old. A total of 656 individuals will eventually take part in the study."

Answered by AI

Are there various locations in this city carrying out the research trial?

"This study is available at 20 different locations, such as the University of California in Davis and San Francisco, as well as the University of Colorado Denver in Aurora. Additionally, there are 17 other clinical sites that have been approved for patient recruitment."

Answered by AI

Who else is applying?

What site did they apply to?
Essential Access Health
Case Western
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

I need birth control.
PatientReceived 1 prior treatment
Recent research and studies
clinicaltrials.govStudy
Contraceptive Efficacy Study of Ovaprene
2023. "Contraceptive Efficacy Study of Ovaprene". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06127199.
All > Vancouver > Honolulu
~437 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top